| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |